Literature DB >> 15327599

The conclusion that 'ultramolecular homeopathy has no observable clinical effects' is not supported by the data.

Edward Shalts, Samuel Shiflett.   

Abstract

Mesh：

Year:  2004        PMID： 15327599      PMCID： PMC1884574          DOI： 10.1111/j.1365-2125.2004.02127.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  Can homeopathically prepared mercury cause symptoms in healthy volunteers? A randomized, double-blind placebo-controlled trial.

Authors:  A J Vickers; R van Haselen; M Heger
Journal:  J Altern Complement Med       Date:  2001-04       Impact factor: 2.579

2.  Randomized double-blind placebo-controlled trial of homoeopathic 'proving' for Belladonna C30.

Authors:  K Goodyear; G Lewith; J L Low
Journal:  J R Soc Med       Date:  1998-11       Impact factor: 5.344

3.  Ultramolecular homeopathy has no observable clinical effects. A randomized, double-blind, placebo-controlled proving trial of Belladonna 30C.

Authors:  Sarah Brien; George Lewith; Trevor Bryant
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

4.  Are postal questionnaire surveys of reported activity valid? An exploration using general practitioner management of hypertension in older people.

Authors:  M Eccles; G A Ford; S Duggan; N Steen
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

5.  Does a highly diluted homoeopathic drug act as a placebo in healthy volunteers? Experimental study of Belladonna 30C in double-blind crossover design--a pilot study.

Authors:  H Walach
Journal:  J Psychosom Res       Date:  1993-12       Impact factor: 3.006

6.  Importance of sensitivity to change as a criterion for selecting health status measures.

Authors:  R Fitzpatrick; S Ziebland; C Jenkinson; A Mowat; A Mowat
Journal:  Qual Health Care       Date:  1992-06

7.  Validity of self-assessment outcome questionnaires: patient-physician discrepancy in outcome interpretation.

Authors:  Ashraf A Ragab
Journal:  Biomed Sci Instrum       Date:  2003

8.  The end-of-study patient survey: methods influencing response rate in the AVID Trial.

Authors:  Ellen Graham Renfroe; Geoff Heywood; Lynne Foreman; Eleanor Schron; Judy Powell; Christina Baessler; Deborah Warwick; Mary Morris; Alfred Hallstrom
Journal:  Control Clin Trials       Date:  2002-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.